LIVIVO - Search results -

Search results

Result 1 - 10 of total 16

Search options

Article ; Online: Pleuran-β-Glucan from Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Soothes and Improves Skin Parameters.

Schiano, Irene / Raco, Stefania / Cestone, Enza / Jesenak, Milos / Rennerova, Zuzana / Majtan, Juraj

International journal of medicinal mushrooms

2022 Volume 23, Issue 12, Page(s) 75–83

Abstract: Ultraviolet (UV) radiation, particularly UVB radiation, is one of the major risk factors for environmentally influenced skin disorders. β-D-glucans represent a class of natural compounds, and their use in the cosmetic and pharmaceutical industries is ... ...

Abstract	Ultraviolet (UV) radiation, particularly UVB radiation, is one of the major risk factors for environmentally influenced skin disorders. β-D-glucans represent a class of natural compounds, and their use in the cosmetic and pharmaceutical industries is increasing. The goal of this study was to evaluate the soothing effect of a β-glucan pleuran-based cream against skin alterations caused by a solar simulator (UVA/UVB exposure) and to assess the efficacy of the cream after 30 days of use on the face and body in 20 human subjects with all skin types (sensitive, atopic, and normal) and phototypes II and III. The study consisted of the following two tests: one short term and one long term. In the short-term test, the minimal erythemal dose was determined by applying a pattern of radiation consisting of six doses of UVA+UVB radiation and was visually assessed 24 h after UV exposure. In the long-term test, pleuran-based cream was applied twice a day on both the nonirradiated face and body of all subjects for a 30-day period. Subsequently, noninvasive techniques such as skin moisture, skin brightness/radiance, skin elasticity, and total antioxidant capability were utilized. The pleuran-based cream had a positive effect on erythema induced by UV exposure, with visibly reduced erythema compared to the control area. Moreover, long-term use of the cream over a 30-day period improved all monitored skin parameters on the face and body. In summary, these results indicate that β-glucans can be used as an active ingredient with UV light-protective and soothing properties after UV exposure for the cosmetic and pharmaceutical industries.
MeSH term(s)	Animals ; Antioxidants/pharmacology ; Glucans/pharmacology ; Humans ; Ostreidae ; Pleurotus ; Skin ; Ultraviolet Rays/adverse effects ; beta-Glucans/pharmacology
Chemical Substances	Antioxidants ; Glucans ; beta-Glucans
Language	English
Publishing date	2022-04-05
Publishing country	United States
Document type	Journal Article
ZDB-ID	2108803-2
ISSN	1940-4344 ; 1521-9437
ISSN (online)	1940-4344
ISSN	1521-9437
DOI	10.1615/IntJMedMushrooms.2021041519
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Bonn / Germany

Z 7482: Show issues

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- See ZB MED holdings
- Order with fees

Article: Beta-(1,3/1,6)-D-glucan from

Rennerova, Zuzana / Picó Sirvent, Leandro / Carvajal Roca, Eva / Paśnik, Jarosław / Logar, Mateja / Milošević, Katarina / Majtan, Juraj / Jesenak, Milos

Frontiers in pediatrics

2022 Volume 10, Page(s) 999701

Abstract: Preschool children are particularly susceptible to recurrent upper and lower respiratory tract infections due to their immune immaturity and other contributing factors. Preventing and/or treating children suffering from recurrent respiratory tract ... ...

Abstract	Preschool children are particularly susceptible to recurrent upper and lower respiratory tract infections due to their immune immaturity and other contributing factors. Preventing and/or treating children suffering from recurrent respiratory tract infections (RRTIs) is challenging, and it is important to provide more clinical evidence about the safety and efficacy of natural immunomodulating preparations, including β-glucans. The aim of the present study was to assess the incidence of respiratory tract infections (RTIs) in children with a history of RRTIs for a period of 6 months (3 months of pleuran supplementation and 3 months of follow-up) compared with the same period from October to March of the previous year prior to enrolment in the study. A total of 1,030 children with a mean age of 3.49 ± 1.91 years from seven countries were included in this study. The total number of RTIs observed during the study period was significantly lower compared to the same period of the previous year (7.07 ± 2.89 vs. 3.87 ± 3.19;
Language	English
Publishing date	2022-10-14
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2711999-3
ISSN	2296-2360
ISSN	2296-2360
DOI	10.3389/fped.2022.999701
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Efficacy of Pleuran (

Urbancikova, Ingrid / Hudackova, Dana / Majtan, Juraj / Rennerova, Zuzana / Banovcin, Peter / Jesenak, Milos

Evidence-based complementary and alternative medicine : eCAM

2020 Volume 2020, Page(s) 8562309

Abstract: One of the highly prevalent viral pathogens among children and adults causing infection, clinically presenting as herpes labialis, is herpes simplex virus type 1 (HSV-1). The long-term administration of acyclovir, a standard regimen for therapy against ... ...

Abstract	One of the highly prevalent viral pathogens among children and adults causing infection, clinically presenting as herpes labialis, is herpes simplex virus type 1 (HSV-1). The long-term administration of acyclovir, a standard regimen for therapy against HSV-1 infections, can cause viral resistance against this drug. Therefore, the development of natural drugs with low toxicity that are able to enhance host antiviral defense against HSV infection is needed.
Language	English
Publishing date	2020-04-13
Publishing country	United States
Document type	Journal Article
ZDB-ID	2171158-6
ISSN	1741-4288 ; 1741-427X
ISSN (online)	1741-4288
ISSN	1741-427X
DOI	10.1155/2020/8562309
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5995: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis.

Jesenak, Milos / Brndiarova, Miroslava / Urbancikova, Ingrid / Rennerova, Zuzana / Vojtkova, Jarmila / Bobcakova, Anna / Ostro, Robert / Banovcin, Peter

Frontiers in cellular and infection microbiology

2020 Volume 10, Page(s) 364

Abstract: Severe acute respiratory syndrome caused by a novel 2019 coronavirus (SARS-CoV2) represents one of the most studied infectious diseases of today. The number of scientific reports and publications increases exponentially day by day. While the majority of ... ...

Abstract	Severe acute respiratory syndrome caused by a novel 2019 coronavirus (SARS-CoV2) represents one of the most studied infectious diseases of today. The number of scientific reports and publications increases exponentially day by day. While the majority of infected subjects are asymptomatic or show mild symptoms, there is an important proportion of patients who requires hospitalization and, sometimes, intensive care. Immune response to novel coronavirus is complex, involves both innate and adaptive immunity, and is biphasic. Significant differences were observed when comparing severe and non-severe patients. Analysis of the reported results from clinical trials clearly show an involvement of specific cellular immunity (predominantly leucopenia, decreased counts of CD3
MeSH term(s)	Betacoronavirus/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; COVID-19 ; Coronavirus Infections/immunology ; Coronavirus Infections/pathology ; Cytokine Release Syndrome/immunology ; Cytokines/immunology ; Eosinophils/immunology ; Humans ; Lung/pathology ; Pandemics ; Pneumonia, Viral/immunology ; Pneumonia, Viral/pathology ; Prognosis ; SARS-CoV-2 ; Severity of Illness Index
Chemical Substances	Cytokines
Keywords	covid19
Language	English
Publishing date	2020-06-30
Publishing country	Switzerland
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID	2619676-1
ISSN	2235-2988 ; 2235-2988
ISSN (online)	2235-2988
ISSN	2235-2988
DOI	10.3389/fcimb.2020.00364
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: β-Glucans in the treatment and prevention of allergic diseases.

Jesenak, Milos / Banovcin, Peter / Rennerova, Zuzana / Majtan, Juraj

Allergologia et immunopathologia

2014 Volume 42, Issue 2, Page(s) 149–156

Abstract: β-glucans are a group of biologically active polysaccharides of natural origin with a proven pleiotropic immunomodulation effect. Their efficacy has been confirmed in the therapeutic treatment and prevention of various infectious diseases, secondary ... ...

Abstract	β-glucans are a group of biologically active polysaccharides of natural origin with a proven pleiotropic immunomodulation effect. Their efficacy has been confirmed in the therapeutic treatment and prevention of various infectious diseases, secondary immune defects and also of oncologic disorders. Allergic diseases are one of the most frequent diseases and their prevalence continues to increase. They develop as a consequence of dysregulation of the immune system, especially when there is failure in the equilibrium of the response of TH1/TH2 lymphocytes towards TH2. New therapeutic approaches in the treatment of immunopathological conditions (e.g. allergic or oncologic) are directed to restoring the equilibrium among different T lymphocyte subpopulations. Based on in vitro experiments, and also on animal and human clinical studies, there is much evidence for the importance of β-glucans in the treatment and also prevention of allergic diseases; this opens new perspectives on the use of this widespread and popular group of natural substances.
MeSH term(s)	Animals ; Humans ; Hypersensitivity/drug therapy ; Hypersensitivity/immunology ; beta-Glucans/immunology ; beta-Glucans/pharmacology
Chemical Substances	beta-Glucans
Language	English
Publishing date	2014-03
Publishing country	Spain
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID	193144-1
ISSN	1578-1267 ; 0301-0546
ISSN (online)	1578-1267
ISSN	0301-0546
DOI	10.1016/j.aller.2012.08.008
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1165: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Anti-allergic effect of Pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections.

Jesenak, Milos / Hrubisko, Martin / Majtan, Juraj / Rennerova, Zuzana / Banovcin, Peter

Phytotherapy research : PTR

2014 Volume 28, Issue 3, Page(s) 471–474

Abstract: Recurrent respiratory tract infections (RRTIs) present a very important problem in paediatric praxis. As true immunodeficiencies are rare, one of the most important factors assumed to contribute to increased respiratory morbidity is atopy. Several ... ...

Abstract	Recurrent respiratory tract infections (RRTIs) present a very important problem in paediatric praxis. As true immunodeficiencies are rare, one of the most important factors assumed to contribute to increased respiratory morbidity is atopy. Several preparations of natural origin have been used for the prevention of RRTIs, and some of the most effective immunomodulators are biologically active polysaccharides - e.g. ß-glucans. In our randomised, double-blind, placebo-controlled study, we investigated the prevalence of atopy in a group of children with RRTIs and the potential anti-allergic effect of pleuran (ß-glucan isolated from Pleurotus ostreatus) on basic laboratory markers of allergic inflammation. We confirmed that atopy may be an important factor contributing to the increased respiratory morbidity in children with RRTIs. The active treatment with pleuran resulted in a significant reduction of peripheral blood eosinophilia and stabilised the levels of total IgE in serum. This was more evident in atopic subjects. Pleuran showed a potential anti-allergic effect. This previously non-described effect could expand the application of this natural immunomodulator also as a complementary adjuvant therapy in allergic patients.
MeSH term(s)	Anti-Allergic Agents/therapeutic use ; Child ; Child, Preschool ; Double-Blind Method ; Eosinophilia/drug therapy ; Female ; Humans ; Hypersensitivity, Immediate/drug therapy ; Immunoglobulin E/blood ; Male ; Pleurotus/chemistry ; Respiratory Tract Infections/drug therapy ; beta-Glucans/therapeutic use
Chemical Substances	Anti-Allergic Agents ; beta-Glucans ; Immunoglobulin E (37341-29-0)
Language	English
Publishing date	2014-03
Publishing country	England
Document type	Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID	639136-9
ISSN	1099-1573 ; 0951-418X
ISSN (online)	1099-1573
ISSN	0951-418X
DOI	10.1002/ptr.5020
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.B 3092: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis

Jesenak, Milos / Brndiarova, Miroslava / Urbancikova, Ingrid / Rennerova, Zuzana / Vojtkova, Jarmila / Bobcakova, Anna / Ostro, Robert / Banovcin, Peter

Frontiers in Cellular and Infection Microbiology

2020 Volume 10

Keywords	Immunology ; Microbiology (medical) ; Microbiology ; Infectious Diseases ; covid19
Publisher	Frontiers Media SA
Publishing country	ch
Document type	Article ; Online
ZDB-ID	2619676-1
ISSN	2235-2988
ISSN	2235-2988
DOI	10.3389/fcimb.2020.00364
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Order via subito

Details ▾
- Full text online
- Order with fees

Article: Anti‐allergic Effect of Pleuran (β‐glucan from Pleurotus ostreatus) in Children with Recurrent Respiratory Tract Infections

Jesenak, Milos / Hrubisko, Martin / Majtan, Juraj / Rennerova, Zuzana / Banovcin, Peter

Phytotherapy research. 2014 Mar., v. 28, no. 3

2014

Abstract	Recurrent respiratory tract infections (RRTIs) present a very important problem in paediatric praxis. As true immunodeficiencies are rare, one of the most important factors assumed to contribute to increased respiratory morbidity is atopy. Several preparations of natural origin have been used for the prevention of RRTIs, and some of the most effective immunomodulators are biologically active polysaccharides – e.g. ß‐glucans. In our randomised, double‐blind, placebo‐controlled study, we investigated the prevalence of atopy in a group of children with RRTIs and the potential anti‐allergic effect of pleuran (ß‐glucan isolated from Pleurotus ostreatus) on basic laboratory markers of allergic inflammation. We confirmed that atopy may be an important factor contributing to the increased respiratory morbidity in children with RRTIs. The active treatment with pleuran resulted in a significant reduction of peripheral blood eosinophilia and stabilised the levels of total IgE in serum. This was more evident in atopic subjects. Pleuran showed a potential anti‐allergic effect. This previously non‐described effect could expand the application of this natural immunomodulator also as a complementary adjuvant therapy in allergic patients. Copyright © 2013 John Wiley & Sons, Ltd.
Keywords	Pleurotus ostreatus ; atopy ; beta-glucans ; blood ; children ; eosinophilia ; immunoglobulin E ; immunomodulators ; inflammation ; morbidity ; patients ; respiratory system ; therapeutics
Language	English
Dates of publication	2014-03
Size	p. 471-474.
Document type	Article
ZDB-ID	639136-9
ISSN	1099-1573 ; 0951-418X
ISSN (online)	1099-1573
ISSN	0951-418X
DOI	10.1002/ptr.5020
Database	NAL-Catalogue (AGRICOLA)

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.B 3092: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Is asthma caused by atopy (positive skin prick tests)? Epidemiologic evidence suggests a negative answer.

Ronchetti, Roberto / Jesenak, Milos / Ronchetti, Francesco / Rennerova, Zuzana

Inflammation & allergy drug targets

2009 Volume 9, Issue 2, Page(s) 91–96

Abstract: In this paper we shortly discuss epidemiological data on the relationship between asthma and atopy according to recent personal and literature epidemiological publications. The coexistence in several subjects of asthma (and of other "atopic" diseases) ... ...

Abstract	In this paper we shortly discuss epidemiological data on the relationship between asthma and atopy according to recent personal and literature epidemiological publications. The coexistence in several subjects of asthma (and of other "atopic" diseases) and IgE hyperproduction generated the dogma that these two biological conditions are mainly genetic in origin and are linked by a strong casual relationship. In the last decades atopy increased at 5-10 % annual rate and at present atopy prevalence, although variable in different countries, reaches somewhere the prevalence of more than 60 %. Similarly, asthma prevalence increased in the last decades, especially so in western and English speaking countries, reaching in certain countries prevalence values higher than 40 %. For these reasons, although certainly dependent on a genetic predisposition, atopy and asthma can nowadays be considered to be largely determined by environmental factors. Moreover, the analysis of epidemiological data derived from studies conducted worldwide, showed that the prevalence of the two conditions were clearly not correlated so that in certain countries with a 50-60% prevalence of atopy asthma prevalence is lower than 2-6 %, while in other countries asthma prevalence is double than atopy prevalence. Further, in countries with high atopy, the prevalence this conditions is high both in asthmatics and in normal subjects and in the places where asthma prevalence reaches high levels this condition is high both in atopic and non atopic people. In conclusion, epidemiological data show that environmental factors affecting asthma prevalence are different from those affecting atopy prevalence and that subjects bearing one of the two conditions don't show any preferential tendency to develop the other one. From aetiological and pathogenetic point of view asthma and atopy appear to be independent conditions We therefore believe that the association between asthma and atopy demonstrated in almost all the "population studies" (atopy prevalence has always been found 20-30 % higher in asthmatics than in non asthmatic subjects) doesn't prove the existence of a "causal" relationship between the two conditions: this could be a kind of association without causative meaning as is the association between blond hair and blue eyes which in no way can be considered a prove that one of the two conditions is the cause of the other.
MeSH term(s)	Allergens/immunology ; Asthma/epidemiology ; Asthma/immunology ; Histamine/immunology ; Humans ; Hypersensitivity, Immediate/epidemiology ; Hypersensitivity, Immediate/genetics ; Hypersensitivity, Immediate/immunology ; Immunoglobulin E/immunology ; Prevalence ; Skin Tests
Chemical Substances	Allergens ; Immunoglobulin E (37341-29-0) ; Histamine (820484N8I3)
Language	English
Publishing date	2009-11-05
Publishing country	United Arab Emirates
Document type	Journal Article
ZDB-ID	2215862-5
ISSN	2212-4055 ; 1871-5281
ISSN (online)	2212-4055
ISSN	1871-5281
DOI	10.2174/187152810791292791
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5890: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections.

Jesenak, Milos / Majtan, Juraj / Rennerova, Zuzana / Kyselovic, Jan / Banovcin, Peter / Hrubisko, Martin

International immunopharmacology

2013 Volume 15, Issue 2, Page(s) 395–399

Abstract: Objectives: Recurrent respiratory tract infections (RRTIs) represent a very important problem in daily clinical practice because of their significant contribution to morbidity in children. Several natural nutritional supplements have been used in the ... ...

Abstract	Objectives: Recurrent respiratory tract infections (RRTIs) represent a very important problem in daily clinical practice because of their significant contribution to morbidity in children. Several natural nutritional supplements have been used in the prevention of RRTIs, but the clinical efficacy of only a few preparations is supported by scientific evidence. Materials and methods: In a double-blind, placebo-controlled, randomised, multicentre study, we have observed a group of 175 children (aged 5.65 ± 2.39 years) with more than 5 respiratory infections that occurred during the 12 months prior to the beginning of the study. Children were randomised into an active group, treated with Imunoglukan P4H® syrup (with pleuran-β-glucan from Pleurotus ostreatus and vitamin C), or a placebo group (vitamin C only). During the 3 visits, within a 12-month period, questionnaires were completed, and blood samples were examined for immune parameters. Results: In the active group, 36% of the children did not suffer from any respiratory infections throughout the treatment, compared to 21% in the placebo group (p<0.05). Imunoglukan P4H® also significantly decreased the frequency of flu and flu-like disease and the number of lower respiratory tract infections. Imunoglukan P4H® treatment resulted in a statistically significant modulation of humoral and cellular immunity. Conclusions: Results from this study demonstrate that Imunoglukan P4H® is effective in the prevention of RRTIs in children. Furthermore, our results also revealed complex immunomodulatory activity of this product. This is the first double-blind, placebo-controlled study in children with RRTIs that has addressed the preventive effects of pleuran on morbidity caused by respiratory infections.
MeSH term(s)	Adjuvants, Immunologic/administration & dosage ; Adjuvants, Immunologic/adverse effects ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin G/blood ; Immunomodulation ; Immunophenotyping ; Male ; Pleurotus ; Recurrence ; Respiratory Tract Infections/drug therapy ; Respiratory Tract Infections/immunology ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; beta-Glucans/administration & dosage ; beta-Glucans/adverse effects ; beta-Glucans/therapeutic use
Chemical Substances	Adjuvants, Immunologic ; Immunoglobulin G ; beta-Glucans
Language	English
Publishing date	2013-02
Publishing country	Netherlands
Document type	Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID	2043785-7
ISSN	1878-1705 ; 1567-5769
ISSN (online)	1878-1705
ISSN	1567-5769
DOI	10.1016/j.intimp.2012.11.020
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5408: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

Your last searches

More links

Kategorien

In stock of ZB MED Bonn / Germany

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito